Metabolomics-based methods for early disease diagnostics.

Metabolomics-based methods for early disease diagnostics.
复制标题

DOI:
10.1586/14737159.8.5.617
复制
发表时间:
2008-09
影响因子:
5.1
通讯作者:
Raftery D
Raftery D
中科院分区:
医学3区
文献类型:
--
作者:
Gowda GA;Zhang S;Gu H;Asiago V;Shanaiah N;Raftery D

文献摘要

参考文献

被引文献

相似文献

“代谢组学”的新兴领域,其中大量的体液或组织中的小分子代谢物在单个步骤中被定量检测到,有望进行早期诊断,治疗监测和了解许多疾病的发病机理主要集中在核磁共振(NMR)光谱和质谱法(MS)的富含信息上。使用高级化学计量方法的高分辨率方法为转化和临床研究提供了强大的平台,以及在本次审查中,当前的趋势和基于NMR的代谢组合的最新进展和最新的进步介绍了高级的发展NMR和MS方法,改进的多元统计数据分析以及最新在癌症,糖尿病,天生代谢和心血管疾病领域的应用疾病。
The emerging field of “metabolomics,” in which a large number of small molecule metabolites from body fluids or tissues are detected quantitatively in a single step, promises immense potential for early diagnosis, therapy monitoring and for understanding the pathogenesis of many diseases. Metabolomics methods are mostly focused on the information rich analytical techniques of nuclear magnetic resonance (NMR) spectroscopy and mass spectrometry (MS). Analysis of the data from these high-resolution methods using advanced chemometric approaches provides a powerful platform for translational and clinical research, and diagnostic applications. In this review, the current trends and recent advances in NMR- and MS-based metabolomics are described with a focus on the development of advanced NMR and MS methods, improved multivariate statistical data analysis and recent applications in the area of cancer, diabetes, inborn errors of metabolism, and cardiovascular diseases.
DOI: 10.1021/ac050162j
发表时间: 2005-04-15
影响因子: 7.4
作者:
Cody, RB;Laramée, JA;Durst, HD
通讯作者: Durst, HD
DOI: 10.1039/b602614a
发表时间: 2006-01-01
影响因子: 4.9
作者:
Chen, HW;Venter, A;Cooks, RG
通讯作者: Cooks, RG
DOI: 10.1002/cem.785
发表时间: 2003-03-01
影响因子: 2.4
作者:
Barker, M;Rayens, W
通讯作者: Rayens, W
DOI: 10.1002/anie.200602942
发表时间: 2007-01-01
影响因子: 16.6
作者:
Chen, Huanwen;Wortmann, Arno;Zenobi, Renato
通讯作者: Zenobi, Renato
DOI: 10.1158/0008-5472.can-04-4106
发表时间: 2005-04-15
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Cheng, LL;Burns, MA;Wu, CL
通讯作者: Wu, CL